Effects of acupuncture on cardiovascular risks in patients with hypertension: a Korean cohort study

Hyejin Jung1,2, Sujung Yeo3, Sabina Lim1,2

  • 1Research Group of Pain and Neuroscience, East-West Medical Research Institute, 26723Kyung Hee University and WHO Collaborating Center for Traditional Medicine, Seoul, South Korea.

Insights

Acupuncture may significantly reduce major adverse cardiovascular events (MACE), myocardial infarction, and all-cause mortality in hypertensive patients. This study supports acupuncture as a complementary therapy for hypertension management and cardiovascular disease prevention.

Area of Science:

  • Cardiovascular Medicine
  • Integrative Medicine
  • Hypertension Management

Background:

  • Hypertension is a major risk factor for cardiovascular disease.
  • Effective management strategies for hypertension are crucial to reduce cardiovascular morbidity and mortality.
  • Exploring complementary therapies like acupuncture can offer additional benefits.

Purpose of the Study:

  • To investigate the impact of acupuncture on major adverse cardiovascular events (MACE), myocardial infarction, stroke, and death.
  • To assess the effectiveness of acupuncture in hypertensive patients receiving anti-hypertensive medications.
  • To evaluate acupuncture's role in reducing cardiovascular disease burden.

Main Methods:

  • A large cohort of 59,370 hypertensive patients on anti-hypertensives was identified from the Korean NHIS-NSC database (2003-2006).
  • Patients were divided into acupuncture and non-acupuncture groups, followed until MACE, myocardial infarction, stroke, or death.
  • Propensity score matching (PSM) created comparable groups (18,011 each); hazard ratios (HRs) were calculated using Cox proportional hazard models.

Main Results:

  • Acupuncture was associated with significantly lower HRs for MACE (0.83), all-cause mortality (0.73), and myocardial infarction (0.85).
  • Acupuncture significantly reduced the risk of stroke-related mortality, ischemic heart disease mortality, and circulatory system disease mortality.
  • These findings were robust after propensity score matching, indicating a protective effect of acupuncture.

Conclusions:

  • This long-term observational study provides evidence for acupuncture's effectiveness in managing hypertension.
  • Acupuncture may play a role in reducing the incidence of major adverse cardiovascular events and mortality in hypertensive patients.
  • Acupuncture can be considered a valuable complementary therapy for hypertension and cardiovascular disease prevention.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
353
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.5K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
595
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
553
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
462
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
790